InvestorsHub Logo

Chabojilo

02/22/14 12:01 PM

#25514 RE: johnking29 #25513

YES! If anyone can IMPROVE an existing drug and remove harmful side effects then YES! Nothing is preventing AMRN from doing so, nothing prevented GSK from doing so. GSK probably didn't do it because of the no NCE issue! Do YOU THINK THAT IS GOOD FOR PROGRESS? NO!

AMRN deserves an NCE. They offer a superior option, no LDL-C raising, no Atrial Fibrillation warning. They have advanced patient care, period!

I do not want beneficial compounds BURIED in a mixture or a potion where we never learn of their potential because of this nonsensical NCE business.